bioMérieux (EPA:BIM) shares have continued recent momentum with a 30% gain in the last month alone. The full year gain of 40% is pretty reasonable, too. All else being equal, a sharp share price ...
Novo shares have surged more than 20% amid oral Wegovy’s fast start. Elsewhere, Terns opened up room for a potential ...
MARCY L'ÉTOILE, France and SHERBROOKE, QC, Jan. 15, 2024 /CNW/ - bioMérieux, a world leader in the field of in vitro diagnostics, announces the acquisition of LUMED, a software company that has ...
DNA-Based Heat Resistant Mold Test Delivers Deeper Diagnostics in a Fraction of the Time, On-Site Solution is Now Available for Implementation Developed in partnership with historic brand Ocean Spray ...
On September 9, 2025, Altesa BioSciences announced a partnership with bioMérieux to use the BIOFIRE SPOTFIRE respiratory diagnostic platform as the primary point-of-care tool in its upcoming Phase 2B ...
bioMérieux is proud to introduce the VITEK ® MS PRIME, a state-of-the-art MALDI-TOF mass spectrometry instrument designed to streamline microbial identification and significantly improve laboratory ...
MARCY L’ÉTOILE, France--(BUSINESS WIRE)--Regulatory News: bioMérieux (Paris:BIM), a global player in in vitro diagnostics and world leader in food microbiology testing, today announced the acquisition ...
MARCY L’ÉTOILE, France--(BUSINESS WIRE)--Regulatory News: bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, today announces the acquisition of a majority holding in Suzhou ...
A French biotech company, with a large Durham presence, has spent $90 million to buy a San Diego firm that makes diagnostic tests to help doctors diagnose life-threatening problems faster. Stefan ...
- Co-development of Assays and Co-distribution of a Fully Integrated Molecular Platform due for Launch in 2012 - bioMerieux Gains Exclusive Rights in Microbiology - bioMerieux Takes Equity Stake in ...
BioMerieux's net profit fell in the first half, largely due to technology delays, but the company raised its full-year guidance for adjusted earnings. The French medical-equipment group posted a first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results